Illustration: Aïda Amer/Axios

Hospitals in coronavirus hotspots are not scaling back their elective procedures, even as their intensive-care units are filling up with coronavirus patients.

Between the lines: Hospitals are ignoring federal recommendations and their own industry's guidance, which says non-urgent procedures should not restart until there is a "sustained reduction in the rate of new COVID-19 cases in the relevant geographic area for at least 14 days."

The big picture: Federal and state officials encouraged hospitals, doctors and outpatient centers to delay non-urgent care when the coronavirus outbreak ignited in March.

Where it stands: Many elective procedures have resumed in conjunction with states reopening — but now the surge of COVID-19 cases is consuming a lot of hospital beds.

"Elective" care does not mean "unnecessary" care. Many doctors and patients don't want to delay certain treatments any longer.

  • However, hospitals have a financial incentive to keep operating rooms open and beds full. More procedures equals more revenue.
  • That's risky for capacity and infection control.

What they're saying: Federal, state and local officials are mostly deferring to hospitals on whether they should pull back on elective care again.

  • A spokesperson for the Arizona Hospital and Healthcare Association said the group is not advising hospitals on what to do: "They know how to manage their business."
  • The Texas Hospital Association pointed to an executive order from Gov. Greg Abbott that says hospitals in certain hotspot counties "must postpone all surgeries and procedures that are not medically necessary." However, there's a loophole that allows hospitals to pretty much do what they want: "The order does not prohibit any surgery or procedure that would not deplete any hospital capacity needed to cope with the COVID-19 disaster."
  • Some hospital systems, especially those in south Florida, have paused some surgeries. A spokesperson for the Florida Hospital Association said "facility readiness to resume elective surgery will vary by geographic location."
  • The American Hospital Association said in a statement that "there are major differences between slowly and safely resuming elective surgeries and continuing to offer these clinical services once they have resumed."

The bottom line: "Most of these elective procedures are things that need to happen at some point," said Payal Patel, an infectious disease physician at the University of Michigan. "It's really difficult to do guidelines because of how fluid the situation is."

Go deeper

Oct 17, 2020 - Health

Over 1,000 current and ex-CDC officers decry the "politicization" of the agency

President Trump calls on reporters during a news conference with White House coronavirus coordinator Deborah Birx and Centers for Disease Control and Prevention Director Robert Redfield. Photo: Chip Somodevilla/Getty Images

More than 1,000 current and former Centers for Disease Control and Prevention epidemic intelligence officers have signed an open letter, decrying "the ominous politicization" of the agency throughout the coronavirus pandemic.

Why it matters: The CDC is typically at the forefront of the U.S. response to public health crises, but the agency has largely been sidelined during the COVID-19 outbreak, with the White House attempting to control messaging, which, at times, contradicts scientific evidence.

Oct 16, 2020 - Health

Trump administration announces deal with CVS, Walgreens to give COVID-19 vaccine to seniors

Photo: Craig F. Walker/The Boston Globe via Getty Images

The Trump administration announced an agreement on Friday with CVS and Walgreens to distribute coronavirus vaccines to seniors and staff in long-term care facilities for free.

Why it matters: The move could help the president move up in the polls with elderly voters. Seniors, who have been significantly impacted by the virus, helped Trump get elected in 2016, but recent polls have indicated that the group swung sharply against him and toward Joe Biden.

Oct 16, 2020 - Health

Vaccine timeline "to ensure public trust"

Illustration: Sarah Grillo/Axios

Pfizer says people might start getting COVID-19 vaccines before the end of the year, according to a timeline it laid out Friday.

The state of play: By the end of October, the company said it hopes to know whether the vaccine is effective, the Wall Street Journal reports.